| FSMAX | PEGEX | FSMAX / PEGEX | |
| Total Expense Ratio | 0.04 | 1.08 | 3% |
| Annual Report Gross Expense Ratio | 0.04 | 1.28 | 3% |
| Fund Existence | 15 years | 9 years | - |
| Gain YTD | 16.937 | 4.969 | 341% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 40.1B | 1.71B | 2,341% |
| Annual Yield % from dividends | 0.50 | 0.00 | - |
| Returns for 1 year | 23.68 | -4.97 | -477% |
| Returns for 3 years | 72.74 | 5.41 | 1,346% |
| Returns for 5 years | 40.14 | -30.43 | -132% |
| Returns for 10 years | 134.49 | N/A | - |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| GFLW | 34.14 | 0.21 | +0.63% |
| VictoryShares Free Cash Flow Growth ETF | |||
| AMVGX | 17.27 | 0.07 | +0.41% |
| American Century Mid Cap Value R5 | |||
| NAPIX | 84.40 | N/A | N/A |
| Voya Multi-Manager International Sm Cp I | |||
| FPHAX | 35.95 | N/A | N/A |
| Fidelity Select Pharmaceuticals Port | |||
| FEUCX | 22.05 | N/A | N/A |
| Fidelity Advisor Glbl Capital Apprec C | |||